Literature DB >> 8901013

Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord.

M Malcangio1, N G Bowery, R J Flower, M Perretti.   

Abstract

Superfusion of rat spinal cord slices with rat interleukin-1 beta resulted in a significant enhancement of electrically evoked substance P-like immunoreactivity with a maximal effect (> 2-fold increase) at 0.1 ng/ml, whereas higher concentration (10-50 ng/ml) of the cytokine inhibited (approximately 50%) the release of the neuropeptide. Interleukin-1 beta (0.1 ng/ml) potentiation of substance P-like immunoreactivity release was abrogated by co-perfusion with interleukin-1 receptor antagonist (10-100 ng/ml) or with indomethacin (1 microM). Superfusion of spinal cord with interleukin-1 beta inhibited electrically evoked calcitonin gene-related peptide-like immunoreactivity release. Modulation of substance P-like immunoreactivity release from the spinal cord by interleukin-1 beta may represent a mechanism responsible for the hyperalgesic action of the cytokine characteristic of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901013     DOI: 10.1016/0014-2999(95)00845-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system.

Authors:  Y Xia; H Z Hu; S Liu; J Ren; D H Zafirov; J D Wood
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs.

Authors:  Haroon Hameed; Mariam Hameed; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-04

Review 3.  Glia in pathological pain: a role for fractalkine.

Authors:  E D Milligan; E M Sloane; L R Watkins
Journal:  J Neuroimmunol       Date:  2008-06-10       Impact factor: 3.478

Review 4.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

Review 5.  Mindfulness Meditation for Fibromyalgia: Mechanistic and Clinical Considerations.

Authors:  Adrienne L Adler-Neal; Fadel Zeidan
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

6.  Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles.

Authors:  Philipp Klemm; Johanna Becker; Iris Aykara; Thomas Asendorf; Gabriel Dischereit; Elena Neumann; Ulf Müller-Ladner; Uwe Lange
Journal:  Adv Rheumatol       Date:  2021-01-13

7.  Tumor necrosis factor-α increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent manner.

Authors:  E Bałkowiec-Iskra; A Vermehren-Schmaedick; A Balkowiec
Journal:  Neuroscience       Date:  2011-02-16       Impact factor: 3.590

Review 8.  Status of immune mediators in fibromyalgia.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Curr Pain Headache Rep       Date:  2008-06

9.  P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide.

Authors:  Anna K Clark; Amelia A Staniland; Fabien Marchand; Timothy K Y Kaan; Stephen B McMahon; Marzia Malcangio
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

10.  CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury.

Authors:  N Akimoto; K Honda; D Uta; K Beppu; Y Ushijima; Y Matsuzaki; S Nakashima; M A Kido; K Imoto; Y Takano; M Noda
Journal:  Cell Death Dis       Date:  2013-06-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.